Visit the Sensodyne® and Pronamel® stand at the Dentistry Show – stand G40!
This year GSK Consumer Healthcare, one of the world’s leading research-based pharmaceutical and healthcare companies, will be visiting the Dentistry Show and will be showcasing leading oral care brands, Sensodyne® and Pronamel®.
GSK will be revealing the New Sensodyne® Repair & Protect - now with stronger repair*, which offers sensitivity sufferers the benefit of both advanced NovaMin® technology with sodium fluoride in a single formulation. With twice daily brushing Sensodyne® Repair & Protect can create an even harder reparative hydroxyapatite-like layer* over the exposed dentine.1-4
Pronamel® has an optimised fluoride formulation to help minerals penetrate deep into the tooth surface, actively strengthening and re-hardening acid-weakened enamel.?-8 Visit stand G40 to find out further information on how Pronamel® can help protect your patients’ enamel from the effects of erosive tooth wear.
This year GSK will be sponsoring not one but two presentations! Visit the Dental Hygiene Theatre at 14:45 on Friday 22nd April where Ali Lowe will be presenting “The hygienist’s role in prevention”. The second presentation is due to be revealed shortly!
Feel free to ask any of the GSK team about how Sensodyne® and Pronamel® products can help improve your patients’ oral health.
To request sample of GSK products for your patients visit www.gsk-dentalprofessionals.co.uk
Trade Marks are owned by or licensed to the GSK group of companies
References: 1. Parkinson et al. J Clin Dent 2011; 22(3): 74-81. 2. GSK Data on File. ML498. 3. GSK Data on File. ML584. 4. GSK Data on File. ML589. 5. Edwards MI et al. Correlation of Enamel Surface Rehardening and Fluoride Uptake – DSIMS imaging. Presented at IADR. September 2006. 6. Fowler C et al. J Clin Dent, 2006; 17(4): 100-105. 7. Hara AT et al. Caries Res 2009; 43: 57-63. 8. Barlow P et al. J Clin Dent. 2009; 20(6): 192-198.
*Vs. previous formulation. Forms a protective layer over the sensitive areas of the teeth. Brush twice a day for lasting sensitivity protection.
About the author
Related Posts
Comments
By accepting you will be accessing a service provided by a third-party external to https://www.gdpuk.com/
GDPUK Ltd announces sale of intellectual property to leading publisher Cogora Group
GDPUK Ltd today announces the sale of its intellectual property assets to Cogora Group, one of the UK's leading publishers of healthcare brands, events and educational platforms.
The decision to sell GDPUK’s intellectual property forms part of a considered transition to ensure the long‑term stewardship and development of the brand and associated assets. Cogora brings a wealth of experience and expertise to support the continued evolution of the dentistry brand within its wide portfolio of market-leading healthcare publications. Its award-winning titles include Pulse, a long‑standing and widely recognised source of political news and clinical education for GPs, Nursing in Practice, Management in Practice, The Pharmacist, Pulse PCN and Healthcare Leader, as well as two secondary care publications – Hospital Healthcare Europe and Hospital Pharmacy Europe. The purchase will cement Cogora as the biggest publisher of primary care titles in the UK and allow it to bring its expertise in providing news, analysis, opinion and groundbreaking stories to GDPUK, as well as continue giving dentists and dental staff a voice through its website.
“After careful consideration, we believe that Cogora is well positioned to take GDPUK’s intellectual property forward,” said Tony Jacobs, founder, editor and publisher of GDPUK.com . “This transaction provides continuity for the professional community associated with GDPUK and creates opportunities for future growth under experienced ownership.”
Tony will continue involvement in GDPUK on a consulting basis.
GDPUK Ltd has worked to ensure an orderly transfer of the intellectual property and wishes Cogora every success in its future development.